Biomarkers to Breakthroughs: The Latest on Tau and Neurodegeneration

	Alzheimer's Disease
	The latest Alzheimer's disease news from News Medical

Tau blood-based biomarkers (BBMs) are transforming Alzheimer’s disease research and diagnosis. Gain valuable insights into key Tau BBMs like p-Tau 217, p-Tau 231 and BD-Tau and their evolving role in early neurodegeneration diagnosis and monitoring. Stay ahead in AD research and clinical applications.

Learn More

			Novel method for generating antibodies could revolutionize Alzheimer's and Parkinson's research In diseases like Parkinson's and Alzheimer's, specific proteins misfold and clump together, forming toxic aggregates that damage brain cells.

			Study breaks down Alzheimer's treatment effects in clear terms In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from clinical trials showing that both drugs slowed the progression of the disease.

	Lecanemab and donanemab slow Alzheimer’s decline, but is the benefit worth the cost? Study finds that disease-modifying therapies for Alzheimer’s, lecanemab and donanemab, can extend independence in daily activities by up to 13 months, though their clinical relevance remains debated.

	New research sheds light on brain inflammation in Alzheimer's Brain inflammation, while a crucial part of the body's immune response, takes on a detrimental role in Alzheimer's disease.

	Innovative blood test shows potential to replace spinal tap for Alzheimer's diagnosis Up to half of all people living with Alzheimer's Disease in Ireland remain undiagnosed. Now, a new blood test may have the potential to transform patient care, allowing for better diagnosis, earlier interventions and more targeted treatments.

	Researchers discover genetic mutation linked to toxic protein buildup in Alzheimer's The root causes of most forms of Alzheimer's disease largely remain a mystery. Now, researchers have revealed a new piece of the puzzle.

	Vascular changes in brain trauma could trigger Alzheimer’s development An increased risk of dementia among individuals exposed to brain trauma, traumatic brain injury, has been known for almost a century.

	New review sheds light on links between Alzheimer's and metabolic syndrome Alzheimer's disease (AD), the most common form of dementia, continues to remain one of modern medicine's greatest challenges.

	UCLA team identifies brain rhythms linked to seizures in Alzheimer's A UCLA Health research team has identified changes in brain rhythms that indicate seizure activity in Alzheimer's patients.

	FAIR Health launches resource to support Alzheimer's care planning and costs Today, as part of a national initiative funded by The John A. Hartford Foundation (JAHF), the national, independent nonprofit FAIR Health launched a new shared decision-making tool for Alzheimer's disease that features clinical information for self-care and drug therapy options, as well as related cost information.

How would you rate today's newsletter?

Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2025